SCHEMBL20204130

SCHEMBL20204130

C=C(N)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636245 0.97 — —
SCHEMBL10079143 0.93 — —
SCHEMBL11880935 0.86 — —
SCHEMBL19087301 0.73 NOS2 (0.35) —
SCHEMBL18494133 0.73 — —
SCHEMBL13285081 0.73 — —
SCHEMBL20604006 0.72 — —
SCHEMBL5929221 0.72 CES2 (0.42) —
SCHEMBL14023142 0.72 — —
SCHEMBL532571 0.71 CES2 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018098226-A1 BICYCLIC PEPTIDYL INHIBITOR OF TUMOR NECROSIS FACTOR-ALPHA OHIO STATE INNOVATION FOUNDATION (US) 2018-05-31 — — WO disclosed
US-8927587-B2 Chemical compounds PFIZER LIMITED (GB) 2015-01-06 — — US disclosed
US-20130274243-A1 Chemical Compounds PFIZER LTD (GB) 2013-10-17 — — US disclosed
US-20080312457-A1 Process ASTRAZENECA AB (SE) 2008-12-18 — — US disclosed
US-20080293965-A1 Process for the Dynamic Resolution of (Substituted) (R)- or (S)- Mandelic Acid ASTRAZENECA AB (SE) 2008-11-27 — — US disclosed
Send feedback